The total haemolytic complement (CHJO), the complement components C3 and C4, the complement breakdown product C3d, alternative pathway activation and transferrin, were measured before, during and after cardiopulmonary bypass. As expected, CHJO decreased after heparinization, remained low during bypass and decreased further up to 8 h after bypass. C3 and C4 decreased significantly during bypass, continued to decrease for a further 8 h after bypass (by 35% and 40% respectively) and thereafter increased gradually up to 48 h. Although the depletions observed were suggestive of complement activation, there were no demonstrable increases in C3d, and in all patients the concentration of C3d remained within the normal range. Hence it was concluded that complement depletions of this magnitude were unlikely to result from complement activation. Non-specific changes in protein concentrations during bypass, as a result of dilution, redistribution or other unidentified factors, are more probable causes of the observed reductions. The acute phase response to surgery may be a factor in the subsequent increase in C3 and C4 which is seen 24 h after bypass. As transfenn concentrations in the plasma are known to decrease during this response the observed decrease in transfcrrin concentration would support this view.
The potent peptides C3a and C5a which are released when complement is activated are thought to contribute to the pulmonary dysfunction which sometimes follows cardiopulmonary bypass (CPB) and to the pathogenesis of the post perfusion syndrome (Chenoweth et al., 1981) . Both C3a and C5a are known to stimulate release of histamine from mast cells and to cause an increase in vascular permeability (Hugli, 1979) which is a feature of the postperfusion syndrome (Kirklin, 1980) . In addition, plasma C5a concentrations have been shown to be increased in the adult respiratory distress syndrome (ARDS) (Hammcrschmidt et al., 1980) where similar organ dysfunction is seen. The demonstration of complement activation by crossed immunoelectrophoresis (Haslam, Townsend and Branthwaite, 1980) and the generation of C3a and C5a during bypass (Chenoweth et al., 1981) suggested that these fragments could contribute to the postoperative complications associated with CPB. However, de-spite the generation of C3a and C5a the patients studied had no clinical symptoms which could be related to those of active complement fragments either during bypass or in the period after operation.
The present study was undertaken to measure the degree of complement activation during cardiopulmonary bypass by using C3d as an indicator of such activation. Unlike previous studies (Chenoweth et al., 1981) observations were continued up to 48h after the procedure. In addition, transferrin was used as a protein marker.
METHODS

Patients and surgical procedures
Ten male patients undergoing elective coronary artery bypass surgery were studied. Their mean age was 48 yr (range 32-60yr, SD 9yr). Premedication consisting of papaveretum 20 mg, hyoscine 0.4 mg and droperidol 5 mg-was administered i.m. 90 min before arrival in the induction area. Anaesthesia was induced with thiopentone 250-300 mg i.v. and papaveretum 6mg i.v., followed by pancuronium 10 mg i.v. and after intubation was maintained with 67% nitrous oxide in oxygen, incremental doses of papaveretum to a total dose of 1 mgkg" 1 body weight and a further dose of pancuronium 4mg during bypass. The mean arterial pressure was maintained in the range 70-80mm Hg throughout, before bypass with halothane and after bypass with sodium nitroprusside. Surgery consisted of a me-dian sternotomy and placement of four reversed segments of autogenous saphenous vein grafts from the coronary arteries to the aorta.
Cardiopulmonary bypass equipment was standard and comprised an American Optical Pump, and Bentley BOS 10 bubble oxygenator. Cardiotomy filters were used. The pump oxygenator system was primed with Hartmann solution 2 500 ml and sodium bicarbonate 25mmol. After the administration of bovine lung heparin 300 i.u. kg" 1 , bypass was instituted with an initial flow rate of 2.41itremin~1 per m 2 body surface area. During CPB the patients were cooled to 26-28 °C and flow rates were reduced to 1.4 litre min" 1 m" 2 . After aortic cross clamping, myocardial preservation was maintained with 1-1.5 litre of cardioplegia (St Thomas's) solution. After the coronary arterio-venous anastomoses were performed the cross clamp was removed and the aorta-venous anastomoses performed, during which time the patient was gradually rewanned and resumption of cardiac activity occurred spontaneously.
The lungs were ventilated with 50% oxygen in nitrogen 1.5 litre min" 1 throughout bypass. Total bypass time varied between 1 h 10 min and lh30min.
Potassium was administered to maintain a concentration of approximately 4.5 mmol litre" 1 throughout. After removal of the perfusion cannulae protamine was administered in a dose of 1 mg per 300 units of heparin. Coagulation was measured using an automated activated clotting time (Hemochron). At the end of surgery the patients returned to the intensive care unit and were ventilated in the period immediately after operation. Ventilation was terminated and the trachea extubated 4-8 h after surgery. The patients were discharged from hospital 8-10 days later and remained well during this period.
All these patients received 2-3 units of 3-5 day old CPD blood in the period immediately after bypass and after operation a further 1-2 units was administered to restore the haematocrit to normal.
Collection of samples
Samples of venous blood were collected at the times shown in table I for complement assays. Two aliquots of blood were taken. One sample was placed in EDTA for C3d estimation and the other allowed to clot to measure C3, C4, CHJO, alternative pathway activity and transferrin. The cells were separated by centrifugation, and the plasma or serum was sepa- 
Complement measurements
Total haemolytic activity (CHJO) and alternative pathway function were measured as described by Lachmann and Hobart (1978) and the results were expressed as a percentage of the value from a pool of five samples of normal human serum.
Plasma C3 and C4 were measured by single radial immunodiffusion and the results were expressed as a percentage of a pool of five normal human sera.
C3d was measured by the technique of Perrin, Lambert and Miescher (1975) .
All concentrations were corrected for dilution relative to the preoperative haemoglobin concentrations during bypass and in the periods after bypass and after operation using the formula:
Corrected concentration = Measured concentration x initial PC V PCV at time of measurement
Transferrin measurement
An automated, immunoprecipitation assay (Technicon) was used to measure serum transferrin.
RESULTS
No complications were observed in the patients studied during bypass or in the period after operation.
CH. so
A significant decrease in CH50 (P < 0.05) was seen after heparinization compared with the value before (table II) . Haemolytic alternative pathway activity showed changes similar to those in CH50 but these were not significant (table II) .
C3d
C3d concentrations did not change during the period of study and for all patients remained in the normal range (< 2.05 \\% ml" 1 ).
C3andC4
No significant difference was seen between the values of C3 and C4 before operation and their values before bypass. Ten minutes after commencing cardiopulmonary bypass, C3 concentration decreased in all 10 patients (P< 0.005) and thereafter remained reduced up to 60 min. In contrast, C4 decreased gradually during bypass and at 60 min was seen to be reduced in all 10 patients (P<0.0005).
C3 and C4 continued to decline up to 8 h after the termination of bypass. Thereafter, C3 and C4 concentrations increased gradually (fig. 1) ; however, 24 h after bypass they were still significantly less (P<0.005) than the values before operation (table II) .
Transferrin
No differences were seen between the transferrin concentrations before operation and those after heparinization, (table II) . Ten minutes after commencing CPB the plasma transferrin concentration decreased in all 10 patients. The mean concentration was reduced to 69% of the value before operation (P< 0.005) ( fig. 1 ). Unlike C3 and C4, transferrin concentrations returned to normal within 1 h after bypass. Thereafter a slow continuous decrease was observed up to 48 h.
DISCUSSION
The present study demonstrated a reduction in the concentration of C3 and C4 not only during cardiopulmonary bypass (CPB) but also in the period after bypass, an observation which has not been made in previous studies which terminated early in the postoperative period (Hammerschmidt et al., 1981) . An important observation made in other studies (Chenoweth et al., 1981) is that, despite complement changes, no substantial complications were seen in the patients studied and this was also true for the patients in the present study.
The relatively large values of C3 and C4 before operation in these patients could be explained by low values in the standard pool used for the control assays. Alternatively, all the patients were suffering from heart disease and since C3 and C4 are acute phase reactants, the initial values could be expected to be increased in some of these patients.
All the protein concentrations including C3 and C4 were corrected for dilution and since all of them showed a decrease during bypass, it could be assumed that they were all part of a process which may be common to many proteins during bypass. The return of transferrin to pre-bypass concentrations immediately after bypass when C3 and C4 continued to decrease suggests that the reduction in complement concentration after bypass reflects a more specific process. However, as there was no increase in the C3 breakdown product C3d during this period, despite a 40% decrease in complement concentration, it was concluded that complement activation was unlikely to be the cause of this reduction.
Freezing and rewarming blood for complement assays does not cause complement activation in vitro (Garratty, 1970) . The failure to demonstrate an increase in C3d in the present study suggests that hypothermia, with temperatures of 28 °C, does not cause complement activation.
Heparin blocks complement activation (Loos, Volkanis and Stroud, 1976; Raepple, Hill and Loos, 1976 ) and the decrease in CH30 is in keeping with this. Heparin protaminc complexes activate the classical complement pathway (Lachman and Hobart, 1978) , but the absence of an increase in C3d suggests that these did not cause persistent significant activation in the present study.
C3 and C4 are well preserved in CPD stored blood (Schifferli et al., 1982) . Thus in those patients in whom the C3 and C4 concentrations were reduced by 30% and 40%, the 2 -3 units of 3 -5 day old blood which they received in the period immediately after bypass would tend to increase the concentrations of C3 and C4.
The complement concentrations in blood represent a dynamic equilibrium between synthesis, degradation and distribution into various body compartments, for example intravascular and extravascular. The changes observed could be attributable to any or all of these factors. The reductions in concentration of C3 and C4 observed during bypass were unlikely to be a result of reduced synthesis as they occurred too rapidly. However, reduced synthesis could contribute to the further reduction seen after operation as the fractional catabolic rates of C3 and C4 are UlVolr 1 and 1.4%h"' respectively (Ruddy et al., 1976) . Clinical and experimental studies show that some proteins are denatured when exposed to cardiopulmonary bypass equipment. For example Pruitt, Stroud and Scott (1971) have shown, in vitro, that gammaglobulins when exposed to the oxygenator pump system undergo denaturation and precipitation with albumin and that the tendency to form such precipitates increases at lower temperatures. Two studies support the view that this denaturation could also occur in vivo. First, significant reductions of immunoglobulins were seen in patients after CPB (Parker et al., 1972) , but not after other surgical procedures (Hairston et al., 1969) . Second, anti-gammaglobulin antibodies have been demonstrated in the sera of patients who have undergone surgery with CPB (Pretty et al., 1968) . Thus it is conceivable that complement proteins could be similarly denatured without the production of C3d. For instance, the altered complement proteins could bind to erythrocytes, similar to C3c binding to red cells seen during storage of blood (Szymanski and Odgren, 1979) ; or-C3 and C4 per se could bind to red cells as a result of physicochemical changes related to bypass, similar to the way in which C3 and C4 bind to red cells when physicochemical alterations are produced in vitro (Heier, Kornstad and Nordhagen, 1981) .
Although complement activation during bypass has been demonstrated in several studies (Chenoweth et al., 1981 ) the patients did not have any clinical complications which could be related to such activation either during or after surgery, which suggests that the degree of complement activation was insufficient to produce complications. Haslam, Townsend and Branthwaite (1980) demonstrated complement activation by two-dimensional immunoelectrophoresis, not only in patients undergoing cardiopulmonary bypass, but also in patients undergoing thoracotomy without bypass and hence did not provide any real evidence that complement activation is a feature peculiar to bypass. Furthermore, changes in complement were not quantified and hence this study also fails to give any indication of the degree of complement depletion. The demonstration by Chenoweth and his associates (1981) of the appearance of complement fragments C3a and C5a during bypass is conclusivcevidence of complement activation. However, whilst C3a in plasma was shown to increase progressively during bypass, the concentration subsequently decreased after bypass, which is not consistent with continuous activation. This finding is in complete accordance with the present study which failed to demonstrate increased generation of C3d after CPB and justifies the conclusion that the increasing reduction in C3 and C4 seen after bypass in the present study is not related to activation. Moreover, Chenoweth and his associates inferred C5a production by demonstrating increased leucocyte receptor occupancy by this fragment. However, their patients remained clinically well and they did not show an increase in the plasma concentrations of C5a which is the case in patients with organ dysfunction (Hammerschrnidt et al., 1980) . Whereas during cardiopulmonary bypass some complement activation can be detected by sensitive assays (Chenoweth et al., 1981) , the continuing reduction in C3 and C4 concentrations seen after bypass in this study were shown to be unrelated to activation; neither did the patients studied have any clinical complications. It was concluded that the observed changes in C3 and C4 were probably related to some other unidentified mechanism which merits further investigation. Ctmbios no-espedftcoi de las concentracionei de proteinti durtnte It denvaaon reiultantet de It dihicion, de It redistribua6n u otrot factoret no-idennfkadot constituycn las causa* ma* probable* de la* reducoone* obtervada*. Lt respueitt tguda de fase a la cirujia puede ter un factor de lo* tnmentos consecutivos del C3 y del C4 que te verifican 24 h. deipuei de la denvtoon. Puesto que »e tabe que la* concentrtciones de transf errint en d pi««m« btjan durtntc dicha retpuesta, la disminuci6n obcervada en la concentraci&n de tramferrina podria corroborar este panto de vfota.
